Sophiris Bio (SPHS) Reports Q1 Loss of $0.13/Share

Sophiris Bio (NASDAQ: SPHS) reported Q1 EPS of ($0.13), versus ($0.26) reported last year.

For earnings history and earnings-related data on Sophiris Bio (SPHS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c